We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Generac Holdings
GNRC
$11.5B
| $3.12M | 0.08% |
21,765
+12,683
| +140% | +$1.55M |
|
402
Bankunited
BKU
$3.36B
| $3.1M | 0.08% |
87,241
+80,768
| +1,248% | +$2.71M |
|
403
Coeur Mining
CDE
$15.2B
| $3.1M | 0.08% |
350,317
+218,638
| +166% | +$1.59M |
|
404
Jackson Financial
JXN
$8.52B
| $3.1M | 0.08% |
+34,918
| New | +$2.83M |
|
405
Marathon Digital Holdings
MARA
$4.05B
| $3.1M | 0.08% |
+197,594
| New | +$2.83M |
|
406
PVH
PVH
$4.05B
| $3.09M | 0.08% |
45,107
+15,581
| +53% | +$1.13M |
|
407
Eagle Bancorp
EGBN
$863M
| $3.08M | 0.08% |
158,227
+143,820
| +998% | +$2.67M |
|
408
Danaher
DHR
$139B
| $3.08M | 0.08% |
15,573
+12,717
| +445% | +$2.47M |
|
409
JFrog
FROG
$8.89B
| $3.07M | 0.08% |
70,008
+59,860
| +590% | +$2.27M |
|
410
Airbnb
ABNB
$91.8B
| $3.07M | 0.08% |
23,194
-17,968
| -44% | -$2.28M |
|
411
NuScale Power
SMR
$2.74B
| $3.07M | 0.08% |
+77,483
| New | +$1.94M |
|
412
Roivant Sciences
ROIV
$23.9B
| $3.06M | 0.07% |
+271,903
| New | +$2.95M |
|
413
Axalta
AXTA
$7.51B
| $3.06M | 0.07% |
103,208
+70,115
| +212% | +$2.18M |
|
414
Enova International
ENVA
$6.12B
| $3.06M | 0.07% |
27,428
+22,307
| +436% | +$2.13M |
|
415
Harmonic Inc
HLIT
$1.16B
| $3.06M | 0.07% |
322,826
+215,335
| +200% | +$1.96M |
|
416
Okta
OKTA
$23.9B
| $3.05M | 0.07% |
30,545
+11,557
| +61% | +$1.23M |
|
417
Tyson Foods
TSN
$21.4B
| $3.05M | 0.07% |
54,548
+30,713
| +129% | +$1.77M |
|
418
Advance Auto Parts
AAP
$3.51B
| $3.05M | 0.07% |
65,525
+47,210
| +258% | +$1.89M |
|
419
United Natural Foods
UNFI
$3.07B
| $3.05M | 0.07% |
130,677
+116,728
| +837% | +$3.04M |
|
420
OneMain Financial
OMF
$7.41B
| $3.02M | 0.07% |
53,008
+32,568
| +159% | +$1.62M |
|
421
TFI International
TFII
$11.6B
| $3.01M | 0.07% |
+33,616
| New | +$2.84M |
|
422
BioCryst Pharmaceuticals
BCRX
$2.45B
| $3.01M | 0.07% |
336,095
+194,230
| +137% | +$1.81M |
|
423
Spire
SR
$4.8B
| $3M | 0.07% |
+41,076
| New | +$3.08M |
|
424
Inter&Co
INTR
$2.41B
| $2.99M | 0.07% |
401,829
+248,159
| +161% | +$1.65M |
|
425
Cardinal Health
CAH
$54B
| $2.98M | 0.07% |
17,736
-21,080
| -54% | -$3.13M |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.